Alembic Pharmaceuticals informs about press release

01 Apr 2021 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company's joint venture, Aleor Dermaceuticals, has received US Food and Drug Administration (USFDA) Final Approval for Nystatin and Triamcinolone Acetonide Cream USP, 100,000 units/gram and 1 mg/gram. In this regard, the company has enclosed its press release on 1st April, 2021.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

839.55 3.75 (0.45%)
31-Dec-2025 09:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1721.20
Dr. Reddys Lab 1262.00
Cipla 1491.25
Zydus Lifesciences 908.20
Lupin 2087.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×